Simplified liquid-chromotographic analysis for cyclosporin A, and comparison with radioimmunoassay.

We describe a simplified isocratic "high-performance" liquid-chromatographic method for measuring a new immunosuppressive drug, cyclosporin A, in biological fluids with use of its analogs cyclosporin C and cyclosporin D as internal standards. The method is reproducible and accurate and appears to be specific for cyclosporin A; the detection limit is 31 micrograms/L. The chromatographic measurements of the concentration of cyclosporin A in serum of patients receiving the drug were invariably lower than those by radioimmunoassay and the difference became more pronounced the greater the period of time after dosing. Because measurements of cyclosporin A in serum standards were almost identical with both techniques, the differences between the two sets of results for patients' samples suggests that the radioimmunoassay is nonspecific and measures metabolites of cyclosporin A.

[1]  A. Laupacis,et al.  Cyclosporin A: a powerful immunosuppressant. , 1982, Canadian Medical Association journal.

[2]  G. Klintmalm,et al.  Liver transplantation with use of cyclosporin a and prednisone. , 1981, The New England journal of medicine.

[3]  N. Sinclair,et al.  IMMUNOLOGICAL AND PHARMACOLOGICAL MONITORING IN THE CLINICAL USE OF CYCLOSPORIN A , 1981, The Lancet.

[4]  T. Nagao,et al.  Properties of cyclosporin--A-induced graft acceptance. , 1981, Transplantation proceedings.

[5]  M. Boiron,et al.  Cyclosporin-A prophylactic treatment of graft-versus-host disease in human allogeneic bone marrow transplantation: preliminary results. , 1981, Transplantation proceedings.

[6]  S. Thiru,et al.  Lymphoma in renal allograft patients treated with cyclosporin-A as one of the immunosuppressive agents. , 1981, Transplantation proceedings.

[7]  G. Klintmalm,et al.  NEPHROTOXICITY OF CYCLOSPORIN A IN LIVER AND KIDNEY TRANSPLANT PATIENTS , 1981, The Lancet.

[8]  G. Klintmalm,et al.  The use of cyclosporin A and prednisone in cadaver kidney transplantation. , 1980, Surgery, gynecology & obstetrics.

[9]  T. Beveridge,et al.  High-performance liquid chromatographic determination of cyclosporin A in human plasma and urine. , 1980, Journal of chromatography.

[10]  D. Dunn,et al.  Persistent nonspecific immunosuppression after a course of cyclosporin A. , 1980, Transplantation.

[11]  J. Sloane,et al.  CYCLOSPORIN A TO PREVENT GRAFT-VERSUS-HOST DISEASE IN MAN AFTER ALLOGENEIC BONE-MARROW TRANSPLANTATION , 1980, The Lancet.

[12]  D. Dunn,et al.  CYCLOSPORIN A INITIALLY AS THE ONLY IMMUNOSUPPRESSANT IN 34 RECIPIENTS OF CADAVERIC ORGANS: 32 KIDNEYS, 2 PANCREASES, AND 2 LIVERS , 1979, The Lancet.

[13]  D. Dunn,et al.  CYCLOSPORIN A IN PATIENTS RECEIVING RENAL ALLOGRAFTS FROM CADAVER DONORS , 1978, The Lancet.

[14]  J. Borel,et al.  Effects of the new anti-lymphocytic peptide cyclosporin A in animals. , 1977, Immunology.

[15]  N. Sobol,et al.  Preliminary results , 2020, Asymptotic Analysis of Random Walks: Light-Tailed Distributions.